KENLIFABI
"KENLIFABI" is a word mark owned by Idorsia Pharmaceuticals Ltd, filed at the USPTO on August 27, 2025. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since October 6, 2026
- Filed
- August 27, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99360014
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns KENLIFABI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Idorsia Pharmaceuticals Ltd
IDIA · Allschwil, Switzerland
Representative
Gail I. Nevius Abbas
Jeffer Mangels & Mitchell LLP
What the mark covers
The products and services KENLIFABI is filed for, grouped by Nice class.
Pharmaceutical preparations for human use for the treatment of Fabry disease and symptoms and sequelae of Fabry disease, for the treatment of glycolipid storage disorders, and for the treatment of cancer
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 1 granted
- Sou extension 1 filed
- Sou teas extension received
- Teas change of correspondence received
- Teas withdrawal as domestic representative received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Applicant/correspondence changes (non-responsive) entered
- Teas change of owner address received
10 earlier steps on the official record.
About KENLIFABI
Who owns the trademark "KENLIFABI"?
The USPTO trademark "KENLIFABI" (application 99360014) is owned by Idorsia Pharmaceuticals Ltd.
What is the status of "KENLIFABI"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull KENLIFABI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b1a-c1a0-72cc-9ab1-c97dffc84ee4
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b1a-c1a0-72cc-9ab1-c97dffc84ee4",
"object": "trademark",
"mark_text": "KENLIFABI",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99360014",
"filing_date": "2025-08-27",
"nice_classes": [
5
],
"owners": [
{
"name": "Idorsia Pharmaceuticals Ltd",
"entity_id": "ent_019eb70d-61bd-7356-b4dd-4e764388378a"
}
]
}